Barriers to Small Molecule Drug Discovery for Systemic Amyloidosis

Inhibition of amyloid fibril formation could benefit patients with systemic amyloidosis. In this group of diseases, deposition of amyloid fibrils derived from normally soluble proteins leads to progressive tissue damage and organ failure. Amyloid formation is a complex process, where several individ...

Descripción completa

Detalles Bibliográficos
Autor principal: Morgan, Gareth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230685/
https://www.ncbi.nlm.nih.gov/pubmed/34208058
http://dx.doi.org/10.3390/molecules26123571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230685/
https://www.ncbi.nlm.nih.gov/pubmed/34208058
http://dx.doi.org/10.3390/molecules26123571

Ejemplares similares